PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
02-Sep-2024 Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568 Neurocrine Biosciences
02-Sep-2024 EDX MEDICAL ANNOUNCES AGREEMENT WITH CARIS LIFE SCIENCES TO DISTRIBUTE MOLECULAR PROFILING IN THE UNITED KINGDOM AND NORDIC COUNTRIES EDX Medical Group
02-Sep-2024 BORA PHARMACEUTICALS MAKES A STRATEGIC INVESTMENT INTO TANVEX TO PROVIDE GLOBAL BIOMANUFACTURING SERVICES Bora Pharmaceutical Co., Ltd
02-Sep-2024 More staffing and patient care cuts likely unless government addresses growing NHS deficit The NHS Confederation
02-Sep-2024 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform Medigene AG
02-Sep-2024 ACG Inspection awarded GS1 Nigeria Gold Partnership ACG Inspection
02-Sep-2024 New Service Center in Veeva Vault CRM Suite Unifies Sales and Service Veeva Systems
29-Aug-2024 European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma Janssen-Cilag International NV,
29-Aug-2024 European Commission approves RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer after failure of prior therapy Janssen-Cilag International NV
29-Aug-2024 Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in Great Britain Eisai Europe, Ltd
27-Aug-2024 BioPhorum acquires training organization Brookwood Global BioPhorum
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 Leadership Appointments at RQM+ RQM+
27-Aug-2024 ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse ConTIPI Medical Ltd
27-Aug-2024 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases Celltrion
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024 Medigene AG
27-Aug-2024 RedHill’s Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma RedHill Biopharma
27-Aug-2024 Regeneron Receives EC Approval for Ordspono (odronextamab) to Treat R/R Follicular Lymphoma or R/R Diffuse Large B-cell Lymphoma Regeneron
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica